hours of life.
Methods
The infants studied were enrolled in a multicentre, prospective, randomised clinical trial of surfactant replacement therapy (Curosurf 4). 11 We compared two different dose protocols of porcine surfactant (Curosurf; Chiesi Farmaceutici, Parma, Italy). Curosurf is a natural surfactant isolated from minced pig lungs by a combination of washing, chloroform-methanol extraction, and liquid-gel chromatography.'2 The high dose protocol consisted of a loading dose of 200 mg/kg, followed by up to four subsequent doses of 100 mg/kg; the low dose protocol comprised three doses of 100 mg/kg. Eighty one centres throughout Europe contributed to the study. This analysis relates to the infants from the eight Israeli centres in the study.
DATA COLLECTION
The baseline data collected on each infant included maternal medical and obstetric history, antenatal steroid treatment, mode of delivery, duration of rupture of membranes, single or multiple pregnancy, fetal presentation, Apgar score and sex. Data relating to RDS included ventilator settings before and after treatment and blood gases for all surfactant doses. Outcome was assessed by days of mechanical ventilation, days in 02 (above and below FiO2=0-4), major morbidity, such as air leak complications, sepsis, intraventricular haemorrhage, periventricular leucomalacia, patent ductus arteriosus, necrotising enterocolitis, and retinopathy of prematurity.
Immediate response was defined as the difference between the arterial:alveolar (a:A) ratio immediately before and one hour after the first Curosurf dose (8 a:A ratio). The a:A ratio was calculated according to the following formula:
Pa/AO2=PaO2/(7 13 xFio2)-Paco2. The 8 a:A ratio was calculated for all 253 infants and arranged in ascending order (figure).
The range of 8 a:A ratio was from -0-115 to 0-8. The values obtained were divided into four quartiles, arbitrarily termed very bad, bad, fair and good response for analysis (figure).
DATA ANALYSIS
The influence of the factors described on response type, major morbidity, and mortality was assessed using x2 and Fisher's exact tests for qualitative variables. Pearson's correlation coefficients were computed to assess the association between continuous variables. The independent effect of response type and birth weight on mortality was assessed by trend analysis. Multiple logistic regression analysis was used to assess the relative predictive power of each of the following independent variables (birth weight; gestational age; highest FiO2 and lowest pH in the first 12 hours; Apgar score at five minutes; dose assignment and response type) on dependent variables, including mortality, days of mechanical ventilation, days in 02, length of stay, pneumothorax, other air leak, intraventricular haemorrhage and periventricular leucomalacia.
Preliminary analysis failed to demonstrate any significant differences in response type or outcome in terms of morbidity and mortality between the two dose protocols and therefore, for the purposes of subsequent analysis, the entire population was studied as a whole.
Results
Two hundred and fifty three infants were included in the analysis. Mean The prognostic value of response was also evaluated in relation to morbidity. We found that a low 8 a:A ratio was associated with an increased incidence of pneumothorax.
Bronchopulmonary dysplasia, represented as days with FiO2 of B0 4, or all days in supplemental oxygen, was more common in infants with a poor response, although this did not reach significance (p=0058). Response type did not influence the incidence of intraventricular haemorrhage, periventricular leucomalacia, retinopathy of prematurity, necrotising enterocolitis or apnoea of prematurity. Hamvas similarly reported a higher incidence of pneumothorax and pulmonary interstitial emphysema in the 'non-response' group.14 Bronchopulmonary dysplasia was more common in the 'response' group, but this did not reach significance. Charon in his study and the Collaborative European Multicenter Study Group found the same effect of response on pneumothorax and pulmonary interstitial emphysema but could not demonstrate an influence on bronchopulmonary dysplasia. These studies support our findings which show poor response as an important predictor for mortality and early pulmonary morbidity.
Birth asphyxia and perinatal infection can interfere with surfactant production and action.16 Unlike Segerer, we could not show that low Apgar score or infection were related to response type. Segerer suggested that infection has a negative impact on response.6 It must be emphasised that only confirmed sepsis (positive bacterial blood culture) was taken into consideration, though many infants had important clinical signs of sepsis such as hypotension, poor perfusion, leucopenia, and thrombocytopenia but negative blood cultures. Others had been partially treated because of prenatal maternal antibiotic treatment and hence the number of infants with any kind of infection (bacterial, viral, chlamydial, mycoplasmal or fungal) acquired perinatally is unknown. Prevention of infection may be extremely important in increasing response rate and thus improving survival.
Appreciation of the prognostic importance of the immediate response to surfactant may help us identify a high risk group of premature infants in whom new or more aggressive treatment may improve outcome and conversely may reduce the necessity for potentially harmful interventions in those infants who respond appropriately. 
